Live Chat ×
Skip to main content

Pearls and Pitfalls in the Diagnostic Workup of Small Lymph Node Biopsies

This item is expired.

Evaluated by: David B. Kaminsky, M.D., USCAP, January 17, 2016 
Original release date: January 16, 2016
Access to this course expires on: January 16, 2019
CME 0.75 / SAM 0.75

Course Description
Diagnostic Cytopathology is designed to address professional practice gaps in current cytopathology procedures, adjunctive and molecular techniques, diagnostic criteria/interpretations and classification updates for pathologists in daily practice, particularly in the community hospital and private sectors. Cytopathology partners with surgical pathology in providing expedient, accurate, and cost-effective anatomically-based decisions that guide patient care to optimal outcomes. The USCAP faculty is expertly positioned to provide the latest information in diagnosis, molecular pathology and translational research, offering solution-based information as practice changers. This contemporary course is augmented by elective interactive microscopy sessions that unite expert mentors with registrants in an intimate setting simulating clinical sign-out and consultations at 18-head microscopes. The cases are challenging and prone to provocative discussions and imaginative ideas.

Target Audience
Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives
Upon completion of this educational activity, learners will be able to:

  • Have improved their ability to distinguish normal from atypical lymph node architecture on a small biopsy
  • Choose the appropriate immunostaining strategy to determine the presence and identity of a low grade B cell malignancy on small biopsies
  • Show familiarity with the morphologic cues in small biopsies that suggest T cell or Hodgkin lymphoma and strategies to confirm these diagnoses
  • Recognize the features of some of the more common reactive/infectious disorders of the lymph node

The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of .75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The USCAP is approved by the American Board of Pathology (ABPath) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABPath requirements for Continuing Certification (CC). Registrants must take and pass the post-test in order to claim SAMs credit.

Physicians can earn a maximum of .75 SAM credit hours.

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported no relevant financial relationships: Erik Ranheim, M.D., Ph.D.

USCAP staff associated with the development of content for this activity reported no relevant financial relationships.

To earn CME and SAM credit, all learners must take a content-based exam and achieve a minimum score of 80%. If learners do not achieve a passing score of 80%, they have the option to retake the exam. After you pass the test and complete the evaluation, your certificate of completion will be available to view and print by clicking here.

Not a member? 
Click Here